Premium
VYNE Therapeutics Inc (VYNE)
NASDAQ
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its most advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate... VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its most advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.03 | 1.22448979592 | 2.45 | 2.57 | 2.2701 | 83277 | 2.36489997 | CS |
| 4 | -1.415 | -36.3286264442 | 3.895 | 3.895 | 2.2701 | 107223 | 2.69958045 | CS |
| 12 | -0.46 | -15.6462585034 | 2.94 | 4.29 | 2.2701 | 106403 | 2.9864763 | CS |
| 26 | 0.71 | 40.1129943503 | 1.77 | 4.29 | 1.62 | 86124 | 2.71153651 | CS |
| 52 | 0.34 | 15.8878504673 | 2.14 | 4.29 | 1.57 | 80384 | 2.56522253 | CS |
| 156 | -7.96 | -76.245210728 | 10.44 | 14.22 | 1.57 | 346145 | 5.55949852 | CS |
| 260 | -104.08 | -97.6726726727 | 106.56 | 237.6 | 1.57 | 1046757 | 94.83770147 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
